Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 11804
TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649459(US11890279, Compound A19)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649468(US11890279, Compound G7)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649467(US11890279, Compound G6)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649466(US11890279, Compound G2)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649465(US11890279, Compound C5)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649464(US11890279, Compound B3)
Affinity DataEC50:  6.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649463(US11890279, Compound B2)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649463(US11890279, Compound B2)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649462(US11890279, Compound B1)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649462(US11890279, Compound B1)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649461(US11890279, Compound A27)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649460(US11890279, Compound A23)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649460(US11890279, Compound A23)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for cardiac SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649459(US11890279, Compound A19)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649459(US11890279, Compound A19)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for cardiac SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649451(US11890279, Compound A4)
Affinity DataEC50: >1.00E+5nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649458(US11890279, Compound A17)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649458(US11890279, Compound A17)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for cardiac SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649458(US11890279, Compound A17)
Affinity DataEC50:  6.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649457(US11890279, Compound A13)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649457(US11890279, Compound A13)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for cardiac SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649457(US11890279, Compound A13)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649456(US11890279, Compound A12)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649456(US11890279, Compound A12)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for cardiac SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649456(US11890279, Compound A12)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649455(US11890279, Compound A11)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for cardiac SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649454(US11890279, Compound A10)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649453(US11890279, Compound A8)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649452(US11890279, Compound A7)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for cardiac SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649451(US11890279, Compound A4)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for cardiac SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent